We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+12.48%
1 Year Est. Return
+89.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.9M
AUM Growth
+$11M
Cap. Flow
+$3.03M
Cap. Flow %
3.04%
Top 10 Hldgs %
35.87%
Holding
66
New
5
Increased
41
Reduced
11
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 22.05%
2 Consumer Discretionary 19.4%
3 Industrials 16.01%
4 Real Estate 10.61%
5 Consumer Staples 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLAR icon
26
Clarus
CLAR
$129M
$1.68M 1.69%
485,220
+6,215
+1% +$21.1K
FTEK icon
27
Fuel Tech
FTEK
$45.3M
$1.68M 1.68%
667,514
-313,588
-32% -$447K
AVIR icon
28
Atea Pharmaceuticals
AVIR
$380M
$1.63M 1.63%
452,468
+408
+0.1% +$1.22K
CLW icon
29
Clearwater Paper
CLW
$367M
$1.62M 1.62%
59,538
+18,654
+46% +$504K
HOFT icon
30
Hooker Furnishings Corp
HOFT
$159M
$1.54M 1.55%
145,876
+60,304
+70% +$583K
CVGI icon
31
Commercial Vehicle Group
CVGI
$154M
$1.51M 1.52%
912,050
+346,960
+61% +$422K
ALOT icon
32
AstroNova
ALOT
$226M
$1.42M 1.43%
122,844
-5,533
-4% -$49.2K
ALTO icon
33
Alto Ingredients
ALTO
$392M
$1.41M 1.41%
1,221,842
+279,417
+30% +$268K
WHG icon
34
Westwood Holdings Group
WHG
$183M
$1.36M 1.36%
87,068
-37,686
-30% -$588K
MED icon
35
Medifast
MED
$137M
$1.23M 1.23%
87,194
+17,994
+26% +$236K
KYTX icon
36
Kyverna Therapeutics
KYTX
$464M
$1.22M 1.22%
396,763
+542
+0.1% +$1.34K
TWIN icon
37
Twin Disc
TWIN
$343M
$1.2M 1.2%
+136,132
New +$1.01M
FDMT icon
38
4D Molecular Therapeutics
FDMT
$537M
$1.18M 1.18%
318,537
+122,684
+63% +$431K
NNDM
39
Nano Dimension
NNDM
$328M
$1.15M 1.15%
+709,312
New +$1.09M
NKTX icon
40
Nkarta
NKTX
$157M
$1.1M 1.1%
663,850
+65,605
+11% +$120K
PLRX icon
41
Pliant Therapeutics
PLRX
$65M
$1.04M 1.04%
893,730
+251,537
+39% +$355K
INVE icon
42
Identive
INVE
$62.4M
$1M 1.01%
308,065
+275
+0.1% +$883
AXR icon
43
AMREP Corp
AXR
$119M
$947K 0.95%
45,229
+148
+0.3% +$3.18K
SEER icon
44
Seer Inc
SEER
$121M
$922K 0.92%
430,750
+354
+0.1% +$709
CRGX
45
DELISTED
CARGO Therapeutics
CRGX
$906K 0.91%
219,809
+732
+0.3% +$3.13K
UEIC icon
46
Universal Electronics
UEIC
$60.6M
$835K 0.84%
126,085
+15,203
+14% +$92.9K
MGX icon
47
Metagenomi Therapeutics
MGX
$45.7M
$752K 0.75%
508,109
+155,652
+44% +$244K
CLYM
48
Climb Bio
CLYM
$714M
$689K 0.69%
555,667
+1,851
+0.3% +$2.3K
ZNTL icon
49
Zentalis Pharmaceuticals
ZNTL
$352M
$649K 0.65%
559,213
+795
+0.1% +$1.05K
ANTX icon
50
AN2 Therapeutics
ANTX
$210M
$618K 0.62%
582,770
+1,917
+0.3% +$2.29K

Similar funds

Peapod Lane Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Peapod Lane Capital held 66 positions worth $99.9M, up 12% from $88.9M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Peapod Lane Capital deployed $3.03M of net new capital in Q2 2025, opening 5 new positions and adding to 41 existing holdings. Its largest new stake was Limoneira: 123,158 shares worth $1.93M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Geospace Technologies, an estimated $1.13M trimmed.

  • Peapod Lane Capital's largest Q2 2025 buy was Limoneira: 123,158 shares worth $1.93M.
  • Peapod Lane Capital added most to Acacia Research in Q2 2025, an estimated $974K increase.
  • Peapod Lane Capital's biggest Q2 2025 reduction was Geospace Technologies, cutting an estimated $1.13M.
  • Peapod Lane Capital fully exited Chimerix, Inc. in Q2 2025, selling an estimated $3.57M.
  • Peapod Lane Capital's ten largest holdings make up 36% of its $99.9M portfolio in Q2 2025.
  • Peapod Lane Capital opened 5 new positions and closed 9 in Q2 2025.
  • Peapod Lane Capital's portfolio value rose 12% quarter-over-quarter to $99.9M.

Based on Peapod Lane Capital's 13F filing for Q2 2025, filed 31 Jul 2025.